Incorporated in 2010, JFL Life Sciences Limited is engaged in the business of manufacturing of pharmaceutical products. The company’s product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage form and Tablet and capsules (general) Solid Oral Dosage Form and Oral rehydration solutions (ORS).
The company’s sales strategy is to sell the products in bulk to pharmaceutical marketers and traders who in turn provide the channel for sales to customers. JFL Life Sciences Limited has a market presence in PAN India and JFL’s products are supplied to 10 developed and developing countries throughout the World.
JFL Life Sciences Limited exports products to African, Middle Eastern, and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing a particular product. Few of our products are also registered with Ukraine, Uzbekistan, and Kazakhstan (CIS countries) through merchants.
JFL has two manufacturing units (on lease) in Gujarat.
Competitive Strength :
- Product registration
- Experienced management and dedicated employee base
- Quality assurance
- Quality & Brand strength
|Period Ended||Total Assets||Total Revenue||Profit After Tax||Net Worth||Reserves and Surplus|
|Amount in ₹ Lakhs|
Objects of the Issue
The Company proposes to utilize the funds which are being raised through this Issue (“Net Proceeds”) towards the following objects:
- Repayment of secured and unsecured loans.
- Funding the working capital requirements of the company.
- General Corporate Purposes
|JFL Life Sciences IPO Date||Aug 25, 2022 to Aug 30, 2022|
|JFL Life Sciences IPO Face Value||₹10 per share|
|JFL Life Sciences IPO Price||₹61 per share|
|JFL Life Sciences IPO Lot Size||2000 Shares|
|Issue Size||2,978,000 shares of ₹10|
(aggregating up to ₹18.17 Cr)
|Fresh Issue||2,978,000 shares of ₹10|
(aggregating up to ₹18.17 Cr)
|Issue Type||Fixed Price Issue IPO|
|Listing At||NSE SME|
|Retail Shares Offered||50% of the net offer|
|NII (HNI) Shares Offered||50% of the net offer|
|Company Promoters||Smiral Ashwinkumar Patel and Tejal Smiral Patel are the company promoters.|
IPO opens on Aug 25, 2022, and closes on Aug 30, 2022. IPO bid date is from Aug 25, 2022 10.00 A.M. to Aug 30, 2022 5.00 P.M. The Cut-off time for UPI Mandate confirmation is 12 P.M. on the next day of issue closing day.
|JFL Life Sciences IPO Opening Date||Aug 25, 2022|
|JFL Life Sciences IPO Closing Date||Aug 30, 2022|
|Basis of Allotment||Sep 5, 2022|
|Initiation of Refunds||Sep 6, 2022|
|Credit of Shares to Demat||Sep 7, 2022|
|JFL Life Sciences IPO Listing Date||Sep 8, 2022|
IPO Lot Size
The IPO lot size is 2000 shares. A retail-individual investor can apply for up to 1 lots (2000 shares or ₹122,000).
IPO Promoter Holding
|Pre Issue Share Holding||92.52%|
|Post Issue Share Holding||67.47%|
Company Contact Information
JFL Life Sciences Limited
309, Satyam Mall,
Opp. Saman Complex, Nr. Vishweshwar Mahadev Mandir
Settelite, Ahmedabad 380015
Phone: 937729 5575
Email: [email protected]
IPO Lead Manager(s)
- GYR Capital Advisors Limited